1Ardehali H,Yano Y,Printz RL,et al.Functional organization of mammalian hexokinase Ⅱ.Retention of catalytic and regulatory functions in both the NH2-and COOH-terminal halves[J].J Biol Chem,1996,271(4):1849-1852.
2Adams V,Kempf W,Hassam S,et al.Determination of hexokinase isoenzyme Ⅰ and Ⅱ by RT-PCR:increased hexokinase Ⅱ isoenzyme in human renal cell carcinoma[J].Biochem Mol Med,1995,54(1):53-58.
3Sebastian S,Kenkare UW.Expression of two type Ⅱ-like tumour hexokinase RNA transcripts in cancer cell lines[J].Tumour Biol,1998,19(4):253-260.
4Mazurek S,Eigenbrodt E,Failing K,et al.Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells[J].J Cell Physiol,1999,181(1):136-146.
5Shinohara Y.Identification and characterization of hexokinase isozyme predominantly expressed in malignant tumor cells.Yakugaku Zasshi,2000,120(8):657-666.
6Shinohara Y,Ishida T,Hino M,et al.Characterization of porin isoforms expressed in tumor cells[J].Eur J Biochem,2000,267 (19):6067-6073.
7Golshani-Hebroni SG,Bessman SP.Hexokinase binding to mitochondria:a basis for proliferative energy metabolism[J].J Bioenerg Biomembr,1997,29(4):331-338.
8Robey RB,Hay N.Mitochondrial hexokinases:guardians of the mitochondria[J].Cell Cycle,2005,4(5):654-658.
9Pastorino JG,Hoek JB,Shulga N.Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase Ⅱ to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity[J].Cancer Res,2005,65(22):10545-10554.
10Rempel A,Mathupal SP,Griffin CA,et al.Glucose catabolism in cancer cells:amplification of the gene encoding type Ⅱ hexokinase[J].Cancer Res.1996 Jun 1; 56 (11):2468-71.
